CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 4 Open-market buy Director bought 197,628 shares
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 510 shares at $0.75 ($383)
- 4 Open-market buy Chief Financial Officer bought 11,000 shares at an average $0.76 ($8,370)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,100 shares at $1.15 ($3,565)
- 4 Open-market buy Director bought 2,500 shares at $1.15 ($2,875)
- 4 Open-market buy Director bought 2,500 shares at $1.05 ($2,625)
- 4 Open-market buy Director bought 6,500 shares at an average $1.31 ($8,495)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at an average $0.86 ($2,580)
- 4 Open-market buy Chief Financial Officer bought 4,186 shares at an average $0.83 ($3,480)
- 4 Open-market buy Director bought 4,600 shares at an average $1.19 ($5,483)
- 4 Open-market buy Director bought 8,200 shares at an average $1.13 ($9,284)
Page 16 of 18 · 345 filings